[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Pages 22532-22534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10273]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-609; NRC-2013-0235]


Northwest Medical Isotopes, LLC; Medical Radioisotope Production 
Facility

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit and record of decision; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC or the Commission) 
is providing notice of the issuance of Construction Permit No. CPMIF-
002 to Northwest Medical Isotopes, LLC (NWMI) and record of decision 
(ROD).

DATES: The construction permit was issued, and is immediately 
effective, May 9, 2018.

ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search

[[Page 22533]]

for Docket ID NRC-2013-0235. Address questions about NRC dockets to 
Jennifer Borges; telephone: 301-287-9127; email: 
[email protected]. For technical questions, contact the 
individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209 or 301-415-4737, or by email to [email protected]. 
For the convenience of the reader, the ADAMS accession numbers are 
provided in a table in the ``Availability of Documents'' section of 
this document.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-2856; email: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Introduction

    Under section 2.106 of title 10 of the Code of Federal Regulations 
(10 CFR), the NRC is providing notice of the issuance of Construction 
Permit No. CPMIF-002 to NWMI and the issuance of the ROD under 10 CFR 
51.102(c). The construction permit, which is immediately effective, 
authorizes NWMI to construct a 10 CFR part 50 production facility 
designed for the production of medical radioisotopes in Columbia, 
Missouri, as described in NWMI's application for a construction permit 
and in evidence received at the mandatory hearing held by the 
Commission. With respect to the application for the construction permit 
filed by NWMI, the NRC finds that the applicable standards and 
requirements of the Atomic Energy Act of 1954, as amended, and the 
Commission's regulations have been met. The NRC finds that any required 
notifications to other agencies or bodies have been duly made and that, 
among other things, there is reasonable assurance that the activities 
authorized by the permit will be conducted in compliance with the rules 
and regulations of the Commission, that safety questions will be 
satisfactorily resolved by the completion of construction, and that, 
taking into consideration siting criteria, the proposed facility can be 
constructed and operated at the proposed location without undue risk to 
the public health and safety, subject to the conditions listed in the 
construction permit. Furthermore, the NRC finds that the licensee is 
technically and financially qualified to engage in the activities 
authorized, and that issuance of the license will not be inimical to 
the common defense and security or to the health and safety of the 
public. Finally, the NRC finds that the findings required by subpart A 
of 10 CFR part 51 have been made.

II. Further Information

    The NRC prepared a safety evaluation report and a final 
environmental impact statement that document the information reviewed 
and the NRC's conclusions. The Commission also issued its Memorandum 
and Order (CLI-18-06), documenting its final decision on the mandatory 
hearing held on January 23, 2018, which serves as the ROD in this 
proceeding. The Commission's final decision authorized the issuance of 
the construction permit for the NWMI medical radioisotope production 
facility, contingent upon the inclusion of a revised safety permit 
condition. The NRC also prepared a document summarizing the ROD to 
accompany its action on the construction permit application that 
incorporates by reference materials contained in the final 
environmental impact statement. In accordance with 10 CFR 2.390 of the 
NRC's ``Agency Rules of Practice and Procedure,'' details with respect 
to this action, including the safety evaluation report, final 
environmental impact statement, summary ROD, and accompanying 
documentation included in the construction permit package, as well as 
the Commission's hearing decision and ROD, are available online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. From this site, persons can access the NRC's ADAMS, which 
provides text and image files of NRC's public documents. In addition, 
prior to its publication as a NUREG document, the NRC staff will update 
the safety evaluation report to reflect the revised permit condition.

III. Availability of Documents

    The documents identified in the following table are available to 
interested persons through one or more of the following methods, as 
indicated.

------------------------------------------------------------------------
                Document                       ADAMS Accession No.
------------------------------------------------------------------------
Construction Permit No. CPMIF-002......  ML18037A308
Commission's Memorandum and Order        ML18123A374
 (CLI[dash]18-06) on the Mandatory
 Hearing (ROD).
Summary of the Record of Decision......  ML18053A074
Safety Evaluation Report Related to the  ML18016A021
 Northwest Medical Isotopes, LLC
 Construction Permit Application for a
 Production Facility.
NUREG-2209, ``Environmental Impact       ML17130A862
 Statement for the Construction Permit
 for the Northwest Medical Isotopes
 Radioisotope Production Facility:
 Final Report''.
NWMI Construction Permit Application...  ML15210A182
                                         ML17257A019
------------------------------------------------------------------------



[[Page 22534]]

    Dated at Rockville, Maryland, this 9th day of May 2018.

    For the Nuclear Regulatory Commission.
Anita L. Lund,
Director, Division of Licensing Projects, Office of Nuclear Reactor 
Regulation.
[FR Doc. 2018-10273 Filed 5-14-18; 8:45 am]
 BILLING CODE 7590-01-P